CD8A and plasma cell myeloma: ECs from the bone marrow of patients with multiple myeloma were found to work as mature APC, being able to do antigen presentation to CD8+ T cells and sustaining a Foxp3 + CD8+ T cell population expressing anti-inflammatory IL-10 and TGF-β and endowed with pro-tumor activity [141].